Interrogation of kinase genetic interactions provides a global view of PAK1-mediated signal transduction pathways

Jae-Hong Kim1, Yeojin Seo1, Myungjin Jo1

  • 1Department of Pharmacology, Brain Science and Engineering Institute, and Department of Biomedical Sciences, BK21 Plus KNU Biomedical Convergence Program, School of Medicine, Kyungpook National University, Daegu, South Korea.

Insights

This study identifies key genes regulating p21-activated kinase-1 (PAK1) in glioma, revealing new therapeutic targets. These findings highlight the importance of mitotic spindle, proteolysis, autophagy, and metabolism in cancer progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Kinases, including p21-activated kinase-1 (PAK1), are crucial in intracellular signaling and implicated in various cancers like glioma.
  • The complete signaling network associated with PAK1 remains incompletely defined.
  • Previous work established a yeast genetic interaction screen to identify candidate PAK1 interactions.

Purpose of the Study:

  • To define the signaling network of PAK1 in glioma.
  • To identify novel therapeutic targets for glioma treatment by examining PAK1 genetic interactions.

Main Methods:

  • A large-scale yeast genetic interaction screen was performed using toxicity as a readout.
  • 19 candidate PAK1 genetic interactions with human orthologs were selected and validated in mammalian cells, brain slice cultures, and orthotopic glioma models.
  • RNA interference (RNAi) and pharmacological inhibition were used to assess the function of candidate interactors.

Main Results:

  • Seven genes (DPP4, KIF11, mTOR, PKM2, SGPP1, TTK, YWHAE) were confirmed to regulate PAK1-induced glioma cell migration.
  • Genes involved in mitotic spindle, proteolysis, autophagy, and metabolism are critical for PAK1-mediated glioma cell migration, drug resistance, and proliferation.
  • AKT1 was identified as a downstream mediator of the PAK1-TTK genetic interaction.

Conclusions:

  • This study provides a comprehensive view of PAK1-mediated signal transduction pathways in glioma.
  • The identified genes and pathways represent potential novel therapeutic targets for glioma therapy.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.6K